Most gynecologic cancers occur sporadically — without a clear hereditary cause. But a meaningful proportion arise in women who carry hereditary cancer syndromes whose clinical implications are profound: dramatically elevated lifetime cancer risks, specific surveillance needs, prophylactic options that substantially reduce those risks, and cascade testing opportunities for family members who may share the same genetic risk. The problem is that most of these women do not know they are at elevated hereditary risk because no one has ever taken a thorough family history and recognized the pattern.
A family history conversation that takes 5 to 10 minutes at a well-woman visit can identify women who need genetic counseling and potentially life-saving risk management. That conversation is a standard component of the well-woman visit at Lapeer Women’s Health.
BRCA-Associated Breast and Ovarian Cancer Syndrome
BRCA1 and BRCA2 mutations are the most clinically significant hereditary cancer gene mutations in women. BRCA1 mutations confer a lifetime breast cancer risk of approximately 55 to 72 percent and an ovarian cancer risk of approximately 40 to 46 percent. BRCA2 mutations confer a lifetime breast cancer risk of approximately 45 to 69 percent and an ovarian cancer risk of approximately 11 to 27 percent. Family history patterns that suggest BRCA mutation include: breast cancer diagnosed before age 50, ovarian cancer at any age, male breast cancer, bilateral breast cancer, multiple family members with breast or ovarian cancer, Ashkenazi Jewish ancestry (where BRCA founder mutations are more prevalent), and triple-negative breast cancer. These patterns on either the maternal or paternal side of the family warrant genetic counseling referral. Learn about genetic testing →
Lynch Syndrome — Hereditary Nonpolyposis Colorectal Cancer
Lynch syndrome is caused by mutations in DNA mismatch repair genes (MLH1, MSH2, MSH6, PMS2, EPCAM) and confers elevated lifetime risks of colorectal cancer (25 to 80 percent depending on the gene), endometrial cancer (15 to 60 percent), and ovarian cancer (5 to 15 percent), as well as elevated risks of several other cancers. Family history patterns that suggest Lynch syndrome include: colorectal cancer at a young age (before 50), multiple family members with colorectal or Lynch-associated cancers, endometrial cancer before age 50, and specific cancer combinations (colorectal plus endometrial, or multiple Lynch cancers in the same person). Lynch syndrome is more common than BRCA mutations and is significantly underdiagnosed.
Ovarian Cancer Family History Without BRCA
Even without a known BRCA mutation, a family history of ovarian cancer in a first-degree relative (mother, sister, daughter) or two second-degree relatives on the same side significantly elevates ovarian cancer risk. Non-BRCA hereditary ovarian cancer syndromes exist, and women with a concerning family history of ovarian cancer who test negative for BRCA should discuss whether additional gene panel testing is warranted with a genetic counselor.
Endometrial Cancer Family History
A family history of endometrial cancer — particularly in a first-degree relative or diagnosed before age 50 — raises the possibility of Lynch syndrome and warrants specific family history evaluation. Sporadic endometrial cancer in older postmenopausal relatives is less likely to reflect hereditary risk than early-onset disease or multiple affected family members. The distinction guides the clinical response: routine education about endometrial cancer symptoms for most women, versus genetic counseling referral when the pattern is concerning.
Gathering a Useful Family History
The most clinically useful family history covers three generations: you, your parents, and your grandparents and their siblings. For each family member with cancer, the most important information is: what type of cancer, what age at diagnosis, and which side of the family (maternal or paternal). Paternal family history of breast and ovarian cancer is equally relevant to maternal family history for BRCA risk — a mistake sometimes made in clinical practice. If you do not know your family cancer history, gathering this information before your well-woman visit significantly enhances the risk assessment conversation.
Family History Review and Pattern Recognition
At the well-woman visit, Dr. Andrei reviews the three-generation family history of cancer, identifies patterns consistent with hereditary cancer syndromes, and provides clinical context for what those patterns mean. Many women with significant hereditary risk have never had it explicitly discussed in a clinical setting.
Genetic Counseling Referral
When family history suggests hereditary cancer syndrome, genetic counseling referral is the appropriate next step. Genetic counselors provide a comprehensive risk assessment, review testing options and their implications, guide the testing decision, and support the patient through result interpretation and management recommendations. The referral is coordinated through our affiliated network.
Risk-Adapted Surveillance and Management
For women with identified hereditary risk, screening and surveillance recommendations are individualized: earlier or more frequent mammography, breast MRI, transvaginal ultrasound surveillance, CA-125 monitoring, discussion of risk-reducing medications (chemoprevention), and timing of risk-reducing salpingo-oophorectomy for appropriate candidates. These recommendations are coordinated between Lapeer Women’s Health and the genetic counseling and oncology team.
Our team at Lapeer Women’s Health reviews cancer family history at every well-woman visit. No referral required.
Schedule a Gynecologic VisitEducational purposes only. Not medical advice. Content reviewed by Dr. Ramona D. Andrei, MD PhD FACOG.
Gynecologic care for women of every age
Lapeer Women’s Health — Rochester Hills
2710 S Rochester Rd, Suite 2
Rochester Hills, MI 48307
Serving patients in Lapeer, Rochester Hills, and surrounding communities throughout Southeast Michigan.